Dabrafenib for cutaneous melanoma infiltrating the vitreous: regression of metastasis and occurrence of uveitis as a secondary effect

Dabrafenib for cutaneous melanoma infiltrating the vitreous: regression of metastasis and occurrence of uveitis as a secondary effect

Abstract Intraocular metastasis of cutaneous melanoma is extremely infrequent. This typically occurs in advanced metastatic disease and has a poor survival prognosis. The most frequent reported treatment is radiotherapy. BRAF inhibitors are new, orally administered and very effective drugs used for...

Full description

Bibliographic Details
Main Authors: Alex Fonollosa, Jose Gabriel Vargas-Kelsh, Gonzaga Garay-Aramburu, Angel Saiz, Ignacio Zabalza-Estevez, Ricardo Fernandez
Format: Article
Language:English
Published: SpringerOpen 2017-07-01
Series:Journal of Ophthalmic Inflammation and Infection
Subjects:
Dabrafenib
Cutaneous melanoma
Intraocular metastatic cutaneous melanoma
Metastatic cutaneous melanoma
Uveitis
Online Access:http://link.springer.com/article/10.1186/s12348-017-0135-2

Internet

http://link.springer.com/article/10.1186/s12348-017-0135-2

Similar Items